indias covid vaccintion programme: success or a faliure.
short speech... can u make plz.
Answers
Answer:
Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, Covaxin was approved for emergency use on January 3.
Explanation:
A small percentage of people fully vaccinated against COVID-19 will still develop COVID-19 illness. COVID-19 vaccines are effective. However, a small percentage of people who are fully vaccinated will still get COVID-19 if they are exposed to the virus that causes it. These are called “vaccine breakthrough cases.
Yes, the COVID-19 vaccine introduced in India will be as effective as any vaccine developed by other countries. Various phases of vaccine trials are undertaken to ensure its safety and efficacy
COVID-19 is a bigger risk than vaccine side effects But there are safety nets in place to monitor the COVID-19 vaccines, and they are still working as they should. The COVID-19 vaccines are proven to be overwhelmingly safe for most people
- Hope its helpfull to you